 | Up a level |
M Keshavarzi, Lorestan University of Medical Sciences and G Bjorklund, 2Council for Nutritional and Environmental Medicine, Mo i Rana, and S Chirumbolo, University of Verona, Verona, Italy and M Alimohammad, Mazandaran University of Medical Sciences and H Ehsani, Mazandaran University of Medical Sciences and Z Saadatpour, Isfahan University of Medical Sciences and H Ebrahiminejad, Kerman University of Medical Sciences and H Pourghadamyar, Tehran University of Medical Sciences and B Baghaei, Rafsanjan University of Medical Sciences and HR Mirzaei, Tehran University of Medical Sciences and A Sahebkar, Mashhad University of Medical Sciences and H Mirzaei, Mashhad University of Medical Sciences (2016) Molecular imaging and cancer gene therapy. Cancer Gene Ther, 2016 (00). pp. 1-5.
M Mohammadi, Lorestan University of Medical Sciences and MR Jaafari, Mashhad University of Medical Sciences and HR Mirzaei, Tehran University of Medical Sciences and H Mirzaei, Mashhad University of Medical Sciences (2016) Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Therapy. ISSN 0929-1903
M Mohammadi, Lorestan University of Medical Sciences and E Faghihloo, Shahid Beheshti University of Medical Sciences and Y Araei, 2Pharmaceutical Sciences Branch Islamic Azad University and H Mirzaei, Mashhad University of Medical Sciences and HR Mohammadi, Shiraz University of Medical Sciences and T Mokhtari-Azad6, Tehran University of Medical Sciences (2016) The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line. Cancer Gene Therapy. ISSN 0929-1903
M Mohammadi, Lorestan University of Medical Sciences and M Goodarzi, Katholieke Universiteit Leuven—KU Leuven and MR Jaafari, Mashhad University of Medical Sciences and HR Mirzaei, Tehran University of Medical Sciences and H Mirzaei, Mashhad University of Medical Sciences (2016) Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Therapy. ISSN 0929-1903
